Last update 23 Jan 2025

Zambon Switzerland Ltd.

Subsidiary Company|
Switzerland
|
www.zambon-ch.ch

Overview

Tags

Nervous System Diseases
Otorhinolaryngologic Diseases
Congenital Disorders
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases2
Endocrinology and Metabolic Disease1
Immune System Diseases1
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
MAO-B(Monoamine oxidase B)1
Free radicals1

Related

2
Drugs associated with Zambon Switzerland Ltd.
Safinamide mesylate
Target
MAO-B
Mechanism
MAO-B inhibitors [+1]
Active Org.
MDD US Operations, LLC [+9]
Originator Org.
Newron Pharmaceuticals SpANewron Pharmaceuticals SpA
Active Indication
Parkinson Disease
Inactive Indication
Alzheimer Disease [+11]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
EU [+3]
First Approval Date23 Feb 2015
Acetylcysteine
Target
Free radicals
Mechanism
Free radicals inhibitors
Active Org.
Sannova KK [+8]
Originator Org.
Apothecon LLC
Active Indication
Chemical and Drug Induced Liver Injury [+15]
Inactive Indication
Acute Bronchitis [+7]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date14 Sep 1963
2
Clinical Trials associated with Zambon Switzerland Ltd.
CTR20190490
/ CompletedPhase 1
在中国健康志愿者中评估单次和多次静脉给药N-乙酰半胱氨酸（NAC）的药代动力学、安全性和耐受性的I 期研究
[Translation] A Phase I Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single and Repeated Intravenous Dose N-Acetylcysteine (NAC) in Healthy Chinese Volunteers
CTR20190436
/ CompletedPhase 3
乙酰半胱氨酸在呼吸道疾病和粘液分泌异常患者中的III期多中心随机化、安慰剂和阳性对照药对照、平行分组试验
[Translation] A phase III, multicenter, randomized, placebo- and active comparator-controlled, parallel-group trial of acetylcysteine in patients with respiratory tract disease and mucus secretion disorders
100 Clinical Results associated with Zambon Switzerland Ltd.
Login to view more data
0 Patents (Medical) associated with Zambon Switzerland Ltd.
Login to view more data
100 Deals associated with Zambon Switzerland Ltd.
Login to view more data
100 Translational Medicine associated with Zambon Switzerland Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 02 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
NDA/BLA
1
1
Approved
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Safinamide mesylate
 ( MAO-B )		Parkinson Disease
More
Approved
Acetylcysteine
 ( Free radicals )		Pulmonary Emphysema
More
NDA/BLA
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free